GLP-1s: Beyond weight loss and diabetes Unlocking their potential for myriad chronic conditions Semaglutide and tirzepatide, the active ingredients in such medications as Ozempic/Wegovy and Mounjaro/Zepbound, have been proven to improve metabolic health
Lawsuits Explain How Wegovy and Ozempic Can Cause Stomach Paralysis Problems for Users Novo Nordisk faces lawsuits over inadequate warnings about stomach paralysis caused by Ozempic and Wegovy, which outline how the GLP-1 semaglutide may permanently alter the stomachs natural digestive function
A recent survey from nonprofit Business Group on Health found that employers expect healthcare costs to rise roughly 8% in 2025, largely driven by increased spending on GLP-1 coverage, Healthcare Brew previously reported
With consistent tracking, it becomes easier to see which habits support your goals and which ones might need adjusting
GLP-1, or glucagon-like peptide-1, is a hormone produced in the gut in response to food intake